Chapter review

Fitzgerald PMHNP board review. ch14. Older Adults. This is drive 7 of 7. When I say Pause. Answer. wait, then I will give the answer. New section. Elder Abuse and Caregiver Support. Topic. Caregiver Burden Education. Bottom Line Summary. * **Caregiver burden** correlates directly with the severity of **neuropsychiatric symptoms** (**NPS**), which occur in 98% of patients with **major neurocognitive disorder** (**NCD**). * Up to 50% of patients with **major neurocognitive disorder** experience co-occurring **depression**, making mood screening with tools like the **PHQ-9** essential. * **Cholinesterase inhibitors** (**donepezil**, **rivastigmine**, **galantamine**) provide minor, time-limited cognitive benefits in mild-to-moderate **Alzheimer's disease**; they do not restore pre-disease baseline. Common side effects are **nausea** and **diarrhea**. * **Antipsychotics** (**SGAs** like **brexpiprazole**, **quetiapine**, **risperidone**) carry an FDA **black box warning** for an increased mortality risk of 1.6 to 1.7 times placebo in dementia-related psychosis due to cardiovascular events or pneumonia. * Non-pharmacologic interventions to support caregivers and allow aging in place include **adult day centers**, home safety plans (stove shutoff timers, door alarms), fall prevention, and structured daily routines. * Sudden changes in mental status in older adults indicate **delirium** rather than progressive dementia and require immediate medical evaluation to identify acute underlying causes like **hyponatremia** or infection. Caregiver Burden and Clinical Framework. Family caregivers managing patients with **Alzheimer's disease** face substantial strain driven by progressive cognitive deficits and behavioral disturbances. Caregivers frequently struggle with specific patient symptoms: * Word-finding difficulties and expressive language loss. * Unpredictable angry outbursts triggered by minor environmental changes or routine disruptions. * Apathy and emotional withdrawal, where the patient appears unengaged in daily activities. Unmanaged **neuropsychiatric symptoms** (**NPS**) accelerate caregiver burnout, increase healthcare costs, and lead to earlier institutionalization or nursing home placement. Effective PMHNP caregiver support and education focus on: 1. Connecting families early to community resources such as the **Alzheimer's Association**. 2. Facilitating legal, financial, and end-of-life care planning while the patient retains decision-making capacity. 3. Utilizing **adult day centers** to provide structured patient engagement and essential caregiver respite. 4. Implementing home safety plans, including stove shutoffs, wandering door alarms, fall prevention, and protection from financial scams. High-Yield Clinical Signposts. First-Line. Non-pharmacologic behavioral management and routine stabilization are first-line for behavioral symptoms in **Alzheimer's disease**. Maintain structured daily schedules, avoid environmental disruptions, and use calm reassurance rather than confrontation. Evaluate and treat co-occurring mood disorders using **SSRIs**. Safety Alert. **Antipsychotic** medications carry an FDA **black box warning** when used in older adults with dementia-related psychosis due to a 1.6 to 1.7 times increased risk of death from cardiovascular failure or pneumonia. Reserve **antipsychotics** strictly for severe agitation or direct safety risks. Board Trap. Do not prescribe **second-generation antipsychotics** for routine verbal outbursts, apathy, or mild behavioral changes. Do not promise caregivers that **cholinesterase inhibitors** will reverse cognitive decline or return the patient to pre-disease baseline functioning. Sample Board Practice Question. Question 1. Mrs. Little is a 78-year-old woman with recently diagnosed **Alzheimer's disease** (**AD**) who presents for an office visit with her 55-year-old daughter. According to her daughter, Mrs. Little struggles with word finding and has difficulty following directions. She sometimes seems to "not care about what is going on around her" (apathy), while other times she is engaged in family activities. Her daughter reports that Mrs. Little recently began having angry verbal outbursts triggered by minor problems, stating, "This is not like my mother. Usually she is very patient." Mrs. Little lives with her daughter's family, who wish for her to remain at home as long as it is safe. When evaluating Mrs. Little's healthcare needs, which of the following are pertinent clinical options? (Select all that apply) A) Conduct a home safety evaluation and carry out appropriate modifications. B) Contact healthcare providers as soon as possible if Mrs. Little experiences a sudden change in mental status. C) Recognize that behavioral difficulties in **Alzheimer's disease** frequently arise when regular routines are disrupted. D) Initiate a **cholinesterase inhibitor** with the expectation of restoring her mental status to her pre-disease baseline. E) Evaluate Mrs. Little for a concomitant mood disorder. F) Anticipate that **nausea** and **diarrhea** are the most common adverse effects of **cholinesterase inhibitor** therapy. G) Initiate a **second-generation antipsychotic** to prevent future angry verbal outbursts. Pause. Answer. **Keyed Correct Options:** A, B, C, E, F Why It Is Correct. * Option A is correct because home safety modifications (such as stove timers, fall precautions, and wandering door alarms) protect the patient and support aging in place. * Option B is correct because a sudden mental status change indicates acute **delirium** or medical illness (such as a urinary tract infection or electrolyte imbalance) that requires prompt medical evaluation. * Option C is correct because individuals with **Alzheimer's disease** are highly sensitive to routine changes, which frequently trigger agitation or verbal outbursts. * Option E is correct because depression co-occurs in up to 50% of patients with **major neurocognitive disorder**, making mood evaluation essential. * Option F is correct because gastrointestinal distress, specifically **nausea** and **diarrhea**, represents the primary adverse effect of **cholinesterase inhibitors**. Why the Other Choices Are Wrong. * Option D is wrong because **cholinesterase inhibitors** (**donepezil**, **rivastigmine**, **galantamine**) provide only modest, time-limited cognitive stabilization and do not return patients to their pre-disease baseline. * Option G is wrong because **second-generation antipsychotics** carry an FDA **black box warning** for increased mortality in older adults with dementia-related psychosis and are not indicated for non-emergent verbal outbursts or mild behavioral changes. Next Study Step. Review **delirium etiology and the DELIRIUM mnemonic** in Fitzgerald Chapter 14 to master distinguishing acute reversible confusion from progressive **major neurocognitive disorders**. Next. New section. Cognitive Screening Clue Words. Topic. The Four As and More. Bottom Line Summary. * **Major neurocognitive disorder** requires demonstrable cognitive decline from a prior baseline in one or more of six cognitive domains: learning and memory, executive function, language, perceptual-motor, complex attention, and social cognition. * **The Four As** represent cardinal cognitive deficits in neurocognitive disorders: **aphasia** (language disturbance), **apraxia** (impaired motor activity execution despite intact motor function), **agnosia** (failure to recognize objects or familiar faces despite intact sensory function), and **amnesia** (memory acquisition and recall impairment). * Additional high-yield cognitive screening clue words include **perseveration** (unintentional repetition of words, phrases, or actions), **anomia** (inability to name familiar items), and **executive dysfunction** (loss of planning, organizing, and abstract reasoning). * **First-line** pharmacotherapy for mild-to-moderate **Alzheimer's disease** consists of cholinesterase inhibitors (**donepezil**, **rivastigmine**, **galantamine**), while **memantine** is added for moderate-to-severe stages. * **Safety alert**: All **antipsychotics** carry an FDA boxed warning for increased mortality (1.6 to 1.7 times higher, primarily from sudden cardiac events or pneumonia) when used in older adults with **dementia-related psychosis**. * **Board trap**: **Dementia with Lewy bodies** presents with early visual hallucinations, **REM sleep behavior disorder**, and severe extrapyramidal hypersensitivity to antipsychotics; prominent short-term memory loss is typically absent in early stages. * **Delirium** is distinguished from **dementia** by its acute onset over hours to days, fluctuating course throughout the day, and primary disturbance in attention and awareness. Clinical Teaching: Cognitive Screening Clue Words. The Four As Defined. * **Aphasia**: Impairment of language capability affecting expressive speech or receptive comprehension. Patients in early stages exhibit word-finding hesitation or substitute general terms for specific nouns. In advanced stages, patients rely on vague placeholder phrases such as "those things over there." * **Apraxia**: Impaired ability to execute learned, purposeful motor tasks despite intact primary motor, sensory, and cerebellar systems. Clinical vignettes depict patients who can no longer perform multi-step activities like brushing teeth, buttoning a shirt, or using familiar household tools. * **Agnosia**: Failure to recognize or identify familiar objects, sounds, or family members despite intact primary visual, auditory, and tactile perception. * **Amnesia**: Profound deficit in forming new memories or retrieving established memories. Patients with **major neurocognitive disorder** restate the same thought or repeat the same question multiple times within a single interaction. Related Cognitive Screening Concepts. * **Perseveration**: The continuous, inappropriate repetition of a previously requested word, phrase, movement, or concept beyond the context in which it was initiated. * **Anomia**: Specific inability to recall the names of common objects, forcing the patient to describe the object's function instead of stating its name. * **Executive dysfunction**: Loss of frontally mediated higher-order cognitive management. This manifests as an inability to plan multi-step tasks, organize schedules, maintain mental flexibility, or make sound decisions. It forces reliance on caregivers for instrumental activities of daily living (**IADLs**) such as cooking, paying bills, and managing medications. Differential Diagnosis and Clinical Features. * Contrast of Cognitive Domains in Neurocognitive Decline: * Memory and learning: **Mild NCD** shows increased reliance on calendar lists and delayed recall errors. **Major NCD** shows frequent restating of sentences within the same conversation and loss of task orientation. * Executive function: **Mild NCD** requires extra cognitive effort and causes mental fatigue during multi-step planning. **Major NCD** forces complete reliance on others to plan **IADLs** or causes abandonment of complex tasks. * Language: **Mild NCD** features subtle word-finding delays and minor grammatical errors. **Major NCD** features frequent use of vague terms and loss of specific noun usage. * Perceptual-motor: **Mild NCD** shows subtle spatial disorientation when unassisted. **Major NCD** causes significant inability to navigate familiar environments or operate tools. * Contrast of The Three Ds: * **Delirium**: Acute onset over hours to days, fluctuating course, impaired attention, clouded consciousness, secondary to medical causes (such as UTIs or **hyponatremia**), and potentially reversible. * **Dementia**: Insidious onset over months to years, progressive course, intact primary attention until late stages, clear consciousness, and irreversible. * **Depression**: Subacute onset over weeks, stable course, intact orientation, subjective complaints of poor memory, and reversible with **SSRIs** or psychotherapy. Clinical Practice Signposts. * **First-line**: Initiate a cholinesterase inhibitor (**donepezil**, **rivastigmine**, or **galantamine**) for mild-to-moderate **Alzheimer's disease**. These agents provide modest, time-limited cognitive stabilization but do not restore functioning to pre-disease baseline. * **Board trap**: Avoid prescribing tricyclic antidepressants like **amitriptyline** or sedating antihistamines like **diphenhydramine** in older adults. Their potent anticholinergic profile triggers acute **delirium**, confusion, urinary retention, severe dry mouth, and falls. * **Safety alert**: Monitor serum sodium closely when initiating **SSRIs** (such as **sertraline**) in older adults, especially those taking concomitant thiazide diuretics like **hydrochlorothiazide**. **SSRI-induced hyponatremia** presents with acute confusion, gait instability, and increased fall risk. Board-Style Practice Questions. Question 1. According to the Beers Criteria and START/STOP screening tools, match the medication with the clinical rationale for avoiding or using it with caution in frail older adults: Which medication carries a significant risk of orthostatic hypotension, urinary retention, and fall risk? * A. Zolpidem * B. Amitriptyline * C. Sertraline * D. Donepezil Pause. Answer: B Why correct: **Amitriptyline** is a tricyclic antidepressant with potent anticholinergic and alpha-1 adrenergic blocking properties. It causes orthostatic hypotension, sedation, constipation, urinary retention, and heightened fall risk in older adults. Why distractors fail: * A: **Zolpidem** increases fall and fracture risk primarily through central nervous system depression and motor ataxia, not potent orthostatic hypotension. * C: **Sertraline** carries a primary geriatric risk of **hyponatremia** (especially when combined with diuretics), but has minimal anticholinergic or orthostatic risk. * D: **Donepezil** is a cholinesterase inhibitor used for dementia; its primary adverse effects are gastrointestinal hypermotility (nausea, diarrhea) and bradycardia. Question 2. Mrs. Little is a 78-year-old woman with recently diagnosed **Alzheimer's disease** who struggles with word-finding (**aphasia**), difficulty following multi-step directions (**apraxia**), and periodic angry verbal outbursts triggered by minor routine disruptions. She lives with her daughter, who wishes to maintain her at home. When evaluating her care needs, which of the following is an inappropriate or false clinical management choice? * A. Conduct a home safety evaluation and install door alarms and stove shut-off devices. * B. Instruct the family to contact the provider immediately if a sudden change in mental status occurs. * C. Initiate a second-generation antipsychotic to prevent her periodic angry verbal outbursts. * D. Screen Mrs. Little for a co-occurring mood disorder using a validated tool like the PHQ-9. Pause. Answer: C Why correct: **Second-generation antipsychotics** should never be initiated routinely for non-emergent behavioral outbursts or frustration from routine disruptions. All antipsychotics carry an FDA boxed warning for increased mortality in older adults with dementia. Antipsychotics are reserved strictly for severe agitation or psychosis that poses an immediate physical safety risk. Why distractors fail: * A: Environmental adaptations and home safety evaluations are appropriate non-pharmacological interventions to prevent wandering and burns. * B: Sudden mental status changes suggest acute **delirium** from underlying physical illness (such as a urinary tract infection), requiring immediate medical evaluation. * D: Up to 50 percent of patients with **major neurocognitive disorder** experience co-occurring **major depressive disorder**, making mood screening essential. Question 3. Which of the following is the least likely characteristic or clinical feature of **Alzheimer's disease**? * A. Slowly developing, progressive impairment of cognitive function * B. Chronic condition without spontaneous reversal * C. Prominent early visual hallucinations and perceptual disturbances * D. Progressive loss of independence in instrumental activities of daily living Pause. Answer: C Why correct: Prominent early visual hallucinations and fluctuating cognition are cardinal features of **Dementia with Lewy Bodies**, not **Alzheimer's disease**. In **Alzheimer's disease**, visual hallucinations are uncommon until late, advanced stages. Why distractors fail: * A: **Alzheimer's disease** characteristically presents with an insidious, slow, progressive cognitive decline over 6 to 9 years. * B: **Alzheimer's disease** is a neurodegenerative condition that is permanent and non-reversible. * D: Progressive loss of **IADL** independence (such as managing finances or medications) is a core requirement for diagnosing major NCD due to Alzheimer's. Question 4. A 74-year-old male is evaluated for recent erratic behavior and fluctuating confusion lasting hours at a time up to three times per day over the past month, coinciding with starting a new over-the-counter medication. Which of the following medications is least likely to cause this acute delirium-like presentation? * A. Diphenhydramine * B. Sertraline * C. Haloperidol * D. Diazepam Pause. Answer: B Why correct: **Sertraline** is an **SSRI** that is preferred in older adults and least likely to precipitate acute anticholinergic or sedating **delirium**. Why distractors fail: * A: **Diphenhydramine** possesses potent anticholinergic activity that frequently triggers acute **delirium** and confusion in older adults. * C: **Haloperidol** can precipitate extrapyramidal symptoms, paradoxical agitation, or cognitive worsening in frail elders. * D: **Diazepam** is a long-acting benzodiazepine that accumulates in older adults, causing sedation, ataxia, confusion, and delirium. Question 5. Which of the following clinical features is least likely to be noted as an early symptom in a patient diagnosed with **Dementia with Lewy Bodies**? * A. Prominent short-term memory loss * B. Bradykinesia and muscle rigidity * C. Detailed, well-formed visual hallucinations * D. REM sleep behavior disorder Pause. Answer: A Why correct: Unlike **Alzheimer's disease**, prominent short-term memory impairment is usually absent or minimal in the early stages of **Dementia with Lewy Bodies**. Early stages are dominated by fluctuating cognition, **REM sleep behavior disorder** (dream enactment), and spontaneous parkinsonism. Why distractors fail: * B: Parkinsonian motor signs like bradykinesia, rigidity, and gait instability emerge early in **Dementia with Lewy Bodies** (typically within 1 year of cognitive decline). * C: Recurrent, detailed visual hallucinations are a core diagnostic feature present early in **Dementia with Lewy Bodies**. * D: **REM sleep behavior disorder** often precedes cognitive decline by years in patients with Lewy body pathology. Question 6. In which clinical stage of Major Neurocognitive Disorder do cholinesterase inhibitors such as **donepezil** demonstrate their primary therapeutic benefit? * A. Mild Neurocognitive Disorder * B. Pre-clinical mild cognitive impairment without functional loss * C. Mild to Moderate Alzheimer's Disease * D. Severe end-stage dementia Pause. Answer: C Why correct: **Cholinesterase inhibitors** (**donepezil**, **rivastigmine**, **galantamine**) demonstrate proven clinical efficacy specifically in **mild to moderate Alzheimer's disease** by increasing central synaptic acetylcholine availability. Why distractors fail: * A: **Cholinesterase inhibitors** are not routinely recommended or FDA-approved for **mild neurocognitive disorder** (mild cognitive impairment). * B: Pre-clinical cognitive changes without functional impairment do not warrant cholinesterase inhibitor therapy. * D: In severe to advanced Alzheimer's disease, the NMDA receptor antagonist **memantine** is preferred (either alone or combined with donepezil), as acetylcholine benefits wane. Question 7. A patient with Major Neurocognitive Disorder develops severe bradycardia, gait disturbance, profound muscle rigidity, and tremors after receiving a low dose of a second-generation antipsychotic for visual hallucinations. Which subtype of neurocognitive disorder is most likely present? * A. Alzheimer's Disease * B. Vascular Dementia * C. Frontotemporal Neurocognitive Disorder * D. Dementia with Lewy Bodies Pause. Answer: D Why correct: Patients with **Dementia with Lewy Bodies** possess extreme neuroleptic sensitivity. Administering even low doses of antipsychotics can precipitate severe extrapyramidal symptoms, rigid parkinsonism, profound sedation, or **neuroleptic malignant syndrome**. Why distractors fail: * A: Patients with **Alzheimer's disease** do not exhibit catastrophic neuroleptic sensitivity, although antipsychotics still carry mortality risks. * B: **Vascular dementia** presents with step-wise cognitive decline related to cerebrovascular events without unique neuroleptic hypersensitivity. * C: **Frontotemporal NCD** presents with early behavioral disinhibition, apathy, or hyperorality, without severe extrapyramidal sensitivity to low-dose antipsychotics. Question 8. When evaluating an older adult with a sudden, acute onset of altered mental status over 24 to 48 hours, which of the following diagnostic tests is least essential in the initial emergency workup? * A. Head CT scan * B. Complete Blood Count (CBC) * C. Comprehensive Metabolic Panel (CMP) * D. Electrocardiogram (EKG) Pause. Answer: A Why correct: Acute mental status changes in older adults are overwhelmingly caused by systemic medical issues (such as infections or electrolyte imbalances) rather than acute structural brain lesions. Initial essential workup focuses on lab testing (CBC, CMP, urinalysis) and EKG before neuroimaging unless focal neurological deficits or head trauma are present. Why distractors fail: * B: A **CBC** is essential to evaluate for systemic infection (leukocytosis) precipitating **delirium**. * C: A **CMP** is essential to rule out **hyponatremia**, hypoglycemia, hepatic dysfunction, or renal failure. * D: An **EKG** is essential to evaluate for silent myocardial infarction, arrhythmia, or hypoxia causing cerebral hypoperfusion. Question 9. When considering treatment for a 71-year-old male presenting with mild-to-moderate major depressive disorder, the PMHNP recognizes that which of the following statements regarding geriatric care is false? * A. Psychotropic medications should be initiated at low doses and slowly titrated to therapeutic targets. * B. Electroconvulsive Therapy (ECT) is unsafe and strictly contraindicated in adults over age 65. * C. Renal and hepatic function parameters must be evaluated prior to initiating pharmacotherapy. * D. Antidepressants with minimal anticholinergic side effects should be preferred. Pause. Answer: B Why correct: It is false that **Electroconvulsive Therapy (ECT)** is contraindicated in older adults. **ECT** is proven to be exceptionally safe, rapidly effective, and life-saving for severe, delusional, or treatment-resistant depression in elderly patients. Why distractors fail: * A: "Start low and go slow" is a standard prescribing rule in geriatrics to minimize adverse drug reactions while reaching goal doses. * C: Age-related declines in glomerular filtration and hepatic clearance necessitate baseline lab evaluation to prevent drug accumulation and toxicity. * D: Selecting agents low in anticholinergic activity (avoiding **TCAs** and **paroxetine**) prevents sedation, confusion, urinary retention, and falls. Active Recall Checkpoints. 1. What specific functional boundary differentiates **mild neurocognitive disorder** from **major neurocognitive disorder**? 2. How do you clinically distinguish **aphasia** in mild NCD versus major NCD? 3. What is the classic triad of geriatric psychiatry? 4. What lab monitoring is mandatory when an older adult taking an **SSRI** and a diuretic presents with confusion or falls? 5. Why are **atypical antipsychotics** black-box warned in elderly patients with dementia-related psychosis? Next Best Study Step. Study **Fitzgerald Chapter 14: Delirium Evaluation and Management** next. This is the best next step because mastering the acute etiologies, risk factors, and the **DELIRIUM** mnemonic directly closes the gap between irreversible neurocognitive decline and reversible acute brain failure. It prevents the critical board error of misdiagnosing acute delirium as worsening dementia. Next. Topic. Neurological Exam Signs. Bottom Line. * Up to 50% of patients with major neurocognitive disorder also suffer from co-occurring major depressive disorder, making depression, dementia, and delirium the primary clinical triad in geriatric psychiatry source 1. * Delirium is characterized by an abrupt onset over hours to days, a fluctuating course, and a primary disturbance in attention and awareness, whereas major neurocognitive disorder features an insidious, progressive cognitive decline [2-4]. * Key physical and neurological exam clues signal distinct underlying etiologies: **asterixis** (flapping tremor) indicates hepatic encephalopathy, uremia, or severe metabolic delirium; **nystagmus** suggests alcohol or sedative toxicity/withdrawal or Wernicke encephalopathy; **myoclonus** indicates metabolic encephalopathy or advanced neurocognitive decline; and **Kayser-Fleischer rings** (copper deposits in the cornea) confirm Wilson disease. * **First-line** medical workup for acute mental status changes or suspected delirium includes baseline laboratory testing (**CBC**, **CMP**, **TSH**, **B12**, **urinalysis**, and **serum glucose**) and an **EKG** before ordering neuroimaging such as a head CT scan unless focal neurological deficits or head trauma are present [5-7]. * In patients with **Lewy body disease**, low-dose second-generation antipsychotics trigger severe neuroleptic sensitivity, precipitating marked extrapyramidal symptoms, severe bradycardia, rigidity, and elevated mortality [8, 9]. * **Cholinesterase inhibitors** (such as **donepezil**, **rivastigmine**, and **galantamine**) demonstrate the greatest clinical benefit in mild to moderate **Alzheimer disease**, whereas **memantine** (an NMDA receptor antagonist) is indicated for moderate to severe **Alzheimer disease** [8, 10-12]. * Tricyclic antidepressants (**TCAs**) like **amitriptyline** must be avoided in older adults due to severe anticholinergic toxicity, orthostatic hypotension, and increased fall or fracture risks under the Beers criteria [13-16]. High-Yield Concept Map: Neurological Exam Signs and Cognitive Clues. Asterixis. * **What it is:** Bilateral, involuntary flapping movements of outstretched hands caused by sudden intermittent loss of motor tone. * **Why boards care:** Serves as a classic physical exam marker for metabolic encephalopathy and acute organ failure. * **Must know criteria / features:** Triggered by asking the patient to extend their wrists with fingers spread apart. * **Typical board clue:** Flapping wrist tremor in a confused older adult with elevated liver enzymes or elevated blood urea nitrogen. * **First-line approach:** Identify and treat the underlying systemic metabolic cause, such as hepatic failure or acute renal failure. * **Safety alert:** **Asterixis** signals severe metabolic delirium that requires immediate medical stabilization before any psychiatric diagnosis is assigned. Nystagmus. * **What it is:** Involuntary, rapid, rhythmic oscillation of the eyes. * **Why boards care:** Differentiates toxic-metabolic or neurological emergencies from primary psychiatric disorders. * **Must know criteria / features:** Can be horizontal, vertical, or rotatory; horizontal nystagmus is frequently associated with central nervous system depressant toxicity or thiamine deficiency. * **Typical board clue:** Ataxia, confusion, and ophthalmoplegia/nystagmus in a patient with chronic alcohol use. * **First-line approach:** Administer high-dose parenteral thiamine immediately prior to glucose administration to treat or prevent Wernicke encephalopathy. * **Board trap:** Giving intravenous glucose before thiamine in a patient with nystagmus and alcohol use can precipitate irreversible Korsakoff psychosis. Myoclonus. * **What it is:** Sudden, brief, involuntary shock-like muscle contractions. * **Why boards care:** Distinguishes rapidly progressive neurocognitive disorders, severe drug toxicities, or metabolic encephalopathies from uncomplicated dementia. * **Must know criteria / features:** Present in toxic states, severe delirium, end-stage neurocognitive disorders, and Creutzfeldt-Jakob disease. * **Typical board clue:** Sudden muscle jerks in an elderly patient with acute confusion or rapidly worsening cognitive decline. * **First-line approach:** Perform an urgent medical evaluation and review all current medications for neurotoxic accumulation or drug interactions [4, 17]. Kayser-Fleischer Rings. * **What it is:** Golden-brown or brownish-green copper deposits in the Descemet membrane of the cornea. * **Why boards care:** Pathognomonic physical finding for Wilson disease, an autosomal recessive disorder of copper metabolism that mimics psychiatric illness. * **Must know criteria / features:** Best identified via slit-lamp ophthalmic examination. * **Typical board clue:** Young or middle-aged adult presenting with unexplained psychosis, personality changes, asterixis, tremor, and liver dysfunction. * **First-line approach:** Order serum ceruloplasmin and 24-hour urinary copper excretion tests, then initiate copper-chelating therapy. Compare and Distinguish. Delirium vs. Major Neurocognitive Disorder * Do not confuse: Acute, reversible fluctuation versus chronic, irreversible decline [3, 4]. * Think delirium when: Onset is abrupt over hours to days, course fluctuates, and the cardinal feature is impaired attention and awareness [2, 3]. * Think major neurocognitive disorder when: Onset is insidious over months to years, course is progressive, and attention remains relatively intact in early stages source 4. * Priority difference: Delirium is a medical emergency requiring immediate identification of the underlying physical cause; major neurocognitive disorder requires long-term functional and safety planning [18-21]. * What boards are really testing: Ruling out acute medical causes before diagnosing dementia or depression [5, 6, 22]. * Classic distractor: Assuming acute confusion in an elderly patient is a normal part of aging or routine dementia progression [1, 23]. Lewy Body Disease vs. Alzheimer Disease * Do not confuse: Early visual hallucinations and parkinsonism versus early short-term memory loss [24-26]. * Think Lewy body disease when: Patient presents with early visual hallucinations, fluctuating cognition, REM sleep behavior disorder, and parkinsonian motor signs within one year of cognitive decline [24, 27]. * Think Alzheimer disease when: Patient presents with insidious short-term memory impairment and progressive deficit in learning and executive function without early extrapyramidal signs [28, 29]. * Priority difference: Patients with Lewy body disease have extreme sensitivity to antipsychotics, which can trigger severe rigidity, catatonia, or death [8, 9]. * Board trap: Prescribing haloperidol or risperidone for agitation in Lewy body disease [8, 9]. Common Board Traps and Distractor Logic. Trap 1: Ordering a head CT scan before basic laboratory workup for acute confusion. * Why it looks right: Neuroimaging evaluates structural brain lesions source 30. * Why it is wrong: Acute mental status changes in older adults are far more frequently caused by metabolic derangements, infections, or hypoxia than structural brain lesions [6, 18, 22, 31]. * What makes the correct answer better: Laboratory tests (**CBC**, **CMP**, **urinalysis**, **glucose**) and an **EKG** identify the most common reversible causes faster and more cost-effectively [5-7]. * Board rule to remember: **First-line** evaluation for acute delirium begins with non-invasive lab testing and vital signs before ordering brain imaging unless focal neurological deficits or trauma are documented [5, 6, 32]. Trap 2: Prescribing a second-generation antipsychotic for mild behavioral outbursts. * Why it looks right: Antipsychotics are used for agitation and psychosis source 33. * Why it is wrong: All antipsychotics carry an FDA boxed warning for increased mortality in older adults with dementia-related psychosis, primarily from cardiovascular events or pneumonia [34, 35]. * What makes the correct answer better: Environmental modifications, routine stabilization, and non-pharmacological interventions are preferred first; antipsychotics are reserved strictly for severe agitation that poses an immediate safety risk [36-38]. * Board rule to remember: **Safety alert**: Antipsychotics in elderly patients with neurocognitive disorders carry a 1.6 to 1.7 times increased risk of death source 35. Fitzgerald Board-Style Practice Question Bank. Question 1. An 80-year-old male with a history of mild cognitive impairment is brought to the clinic by his daughter due to an acute onset of confusion over the past two days [2, 4]. During the examination, he struggles to maintain attention, falls asleep mid-sentence, and exhibits brief, involuntary flapping movements of his outstretched hands when extending his wrists [39, 40]. Baseline vital signs reveal a temperature of 98.6 F, heart rate of 88 beats per minute, blood pressure of 138/82 mmHg, and oxygen saturation of 96% on room air. Which diagnostic evaluation should the psychiatric-mental health nurse practitioner order initially? A) Non-contrast head CT scan B) Comprehensive metabolic panel and complete blood count C) Serum ceruloplasmin level D) Lumbar puncture for cerebrospinal fluid analysis **Quick Answer:** The PMHNP should order a comprehensive metabolic panel and complete blood count initially [5, 6]. **Key Clue:** Acute onset over two days with impaired attention and **asterixis** (wrist-flapping tremor) [2, 39, 40]. **Best Answer:** B) Comprehensive metabolic panel and complete blood count **Why It Is Correct:** The patient presents with acute delirium and **asterixis**, which strongly points to a metabolic or organ-failure etiology such as uremia, hepatic dysfunction, or electrolyte imbalance [2, 18, 31, 41]. A comprehensive metabolic panel and complete blood count serve as the essential **first-line** laboratory evaluation to detect metabolic derangements or infection [5, 6]. **Why the Other Choices Are Wrong:** * A: A head CT scan is less essential initially for acute delirium unless focal neurological signs, head trauma, or papilledema are present source 6. * C: Serum ceruloplasmin screens for Wilson disease, which typically presents in younger individuals rather than an acute 80-year-old presentation. * D: Lumbar puncture is invasive and reserved for suspected central nervous system infections like meningitis or encephalitis when systemic lab workup is unrevealing or fever/meningismus is present. **Test-Taking Pearl:** **Asterixis** in an acutely confused older adult is a classic clue for metabolic encephalopathy; always check serum electrolytes, renal function, and liver function first [5, 31]. Question 2. A 75-year-old male with a history of Parkinson disease is evaluated for a three-month history of well-formed visual hallucinations of small animals in his living room, accompanied by fluctuating daytime alertness and dream enactment during sleep [24, 27]. The PMHNP considers initiating low-dose pharmacotherapy for distressing hallucinations source 33. Which medication strategy represents the most significant safety risk for this patient source 8? A) Initiating low-dose quetiapine B) Initiating standard-dose haloperidol C) Ordering a comprehensive medication reconciliation D) Evaluating for co-occurring urinary tract infection **Quick Answer:** Initiating standard-dose haloperidol represents the most significant safety risk [8, 9]. **Key Clue:** Visual hallucinations, fluctuating alertness, and dream enactment indicate **Lewy body disease** / Parkinson disease dementia [24, 27]. **Best Answer:** B) Initiating standard-dose haloperidol **Why It Is Correct:** Patients with **Lewy body disease** or Parkinson disease dementia possess extreme neuroleptic sensitivity [8, 9]. Administering a potent first-generation antipsychotic like **haloperidol** can trigger life-threatening extrapyramidal symptoms, severe rigidity, profound bradycardia, neuroleptic malignant syndrome, and accelerated mortality [8, 9]. **Why the Other Choices Are Wrong:** * A: Quetiapine is one of the preferred low-potency options if an antipsychotic is absolutely necessary, carrying a lower risk of extrapyramidal worsening [33, 42]. * C: Medication reconciliation is a safe and necessary step to identify anticholinergic or dopaminergic triggers [17, 43]. * D: Screening for an acute infection is an essential safety step to rule out superimposed delirium [18, 44]. **Test-Taking Pearl:** **Board trap**: Never prescribe high-potency antipsychotics like haloperidol in suspected Lewy Body disease due to severe neuroleptic sensitivity [8, 9]. Question 3. A 73-year-old female is brought to the emergency department by her family due to sudden onset confusion and disorientation that began four hours ago [2, 7]. On mental status examination, she is unable to perform serial sevens or state the months of the year backward source 40. Which initial diagnostic test is least essential for her immediate medical evaluation source 45? A) Serum glucose level B) Urinalysis C) Liver function tests D) Human immunodeficiency virus (HIV) screening **Quick Answer:** Human immunodeficiency virus (HIV) screening is the least essential initial test for sudden onset mental status change [7, 22]. **Key Clue:** Sudden onset over four hours indicates acute delirium requiring immediate reversible cause screening [2, 7, 18, 22]. **Best Answer:** D) Human immunodeficiency virus (HIV) screening **Why It Is Correct:** An acute, sudden change in mental status over hours is characteristic of delirium caused by immediate physiological triggers such as hypoglycemia, urinary tract infection, or hepatic dysfunction [2, 18, 22]. HIV screening evaluates a chronic infection and is not essential for the immediate emergent workup of acute delirium [5, 7, 22]. **Why the Other Choices Are Wrong:** * A: Serum glucose rapidly identifies hypoglycemia or severe hyperglycemia as a cause of acute confusion [7, 22]. * B: Urinalysis quickly screens for urinary tract infection, a leading cause of delirium in older females [7, 22, 44]. * C: Liver function tests identify hepatic encephalopathy as a potential metabolic trigger [5, 22]. **Test-Taking Pearl:** When evaluating acute, sudden mental status changes, focus on rapid metabolic and infectious rule-outs before chronic disease screening [5, 7, 22]. Question 4. A 71-year-old male presents with mild to moderate major depressive disorder source 46. When formulating the pharmacologic treatment plan, the PMHNP considers evidence-based prescribing guidelines for older adults [17, 47]. Which statement reflects an incorrect clinical principle [48, 49]? A) Psychotropic medications should be started at a low dose and escalated gradually to therapeutic goals [47, 49]. B) Electroconvulsive therapy (ECT) should be strictly avoided in patients over 65 years of age [17, 48, 49]. C) Baseline renal and hepatic function tests should be obtained prior to initiating psychotropic pharmacotherapy [17, 49]. D) Medications with minimal anticholinergic properties should be selected to reduce adverse cognitive effects [13, 14, 50]. **Quick Answer:** The statement that ECT should be avoided in patients over 65 years of age is incorrect [17, 48, 49]. **Key Clue:** Identifying the false treatment principle for geriatric depression [17, 48, 49]. **Best Answer:** B) Electroconvulsive therapy (ECT) should be strictly avoided in patients over 65 years of age [17, 48, 49]. **Why It Is Correct:** Electroconvulsive therapy (ECT) is proven to be safe and highly effective in adults over 65 years of age, especially for severe, delusional, or treatment-resistant depression [17, 48, 49]. Stating that ECT must be avoided in older adults is false [17, 49]. **Why the Other Choices Are Wrong:** * A: Starting low and going slow while titrating to therapeutic goals is a standard geriatric prescribing rule [47, 49]. * C: Baseline renal and hepatic labs are required to assess organ clearance and prevent drug toxicity [5, 17, 49]. * D: Avoiding anticholinergic medications prevents confusion, memory impairment, dry mouth, constipation, and urinary retention [13, 14, 50]. **Test-Taking Pearl:** ECT is a safe, gold-standard treatment option for severe or treatment-resistant depression in elderly adults [17, 49]. Active Recall Checkpoints. 1. What physical exam sign is characterized by a wrist-flapping tremor and signals metabolic encephalopathy? 2. What corneal finding is pathognomonic for Wilson disease? 3. What is the cardinal diagnostic feature that distinguishes delirium from major neurocognitive disorder [2-4]? 4. What severe adverse reaction occurs when patients with Lewy body disease are exposed to typical antipsychotics [8, 9]? 5. What baseline laboratory tests are required before initiating psychotropic medications in an older adult [5, 17, 49]? Next Best Study Step. Study **Fitzgerald Chapter 15: Disorders of Children and Adolescents**. This step transitions your review from geriatric neurocognitive dynamics to pediatric developmental and psychopharmacologic principles, closing key lifespan comparison gaps tested on the ANCC and AANPCB board certification exams. 🧠 **Next Step Idea**: Want to drill a 5-question active recall set on delirium etiology mnemonics and Beers criteria drug interactions, or dive straight into pediatric developmental milestones? Next. End of this drive.